Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
Laura M. Spring, Seth A. Wander, Fabrice André, Beverly Moy, Nicholas C. Turner, Aditya Bardia
Topics & Concepts
PalbociclibMedicineCyclin-dependent kinase 4Metastatic breast cancerBreast cancerCancerInternal medicineOncologyCyclin-dependent kinaseCancer researchReceptor tyrosine kinasePharmacologyCell cycleReceptorCyclin-dependent kinase 2Advanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchCancer-related Molecular Pathways